Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Alf Kastbom; Kristina Forslind; Sofia Ernestam; Pierre Geborek; Johan Karlsson; Ingemar Petersson; Saedis Saevarsdottir; Lars Klareskog; Ronald F van Vollenhoven; Karin Lundberg

doi:10.1136/annrheumdis-2014-205698

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson, Ingemar Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven, Karin Lundberg

Research output: Contribution to journal › Article › peer-review

68 Downloads (Pure)

Abstract

To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic outcome in early rheumatoid arthritis (RA).

Original language	English
Pages (from-to)	356-361
Journal	Annals of the Rheumatic Diseases
Volume	75
Issue number	2
DOIs	https://doi.org/10.1136/annrheumdis-2014-205698
Publication status	Published - 2016

Subject classification (UKÄ)

Clinical Medicine

Access to Document

10.1136/annrheumdis-2014-205698

BMJ__Kastbom_et_al

http://www.ncbi.nlm.nih.gov/pubmed/25550338?dopt=Abstract

Cite this

Kastbom, A., Forslind, K., Ernestam, S., Geborek, P., Karlsson, J., Petersson, I., Saevarsdottir, S., Klareskog, L., van Vollenhoven, R. F., & Lundberg, K. (2016). Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Annals of the Rheumatic Diseases, 75(2), 356-361. https://doi.org/10.1136/annrheumdis-2014-205698

@article{5e8a39dccfe84aabbb235ad92342425c,

title = "Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.",

abstract = "To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic outcome in early rheumatoid arthritis (RA).",

author = "Alf Kastbom and Kristina Forslind and Sofia Ernestam and Pierre Geborek and Johan Karlsson and Ingemar Petersson and Saedis Saevarsdottir and Lars Klareskog and {van Vollenhoven}, {Ronald F} and Karin Lundberg",

year = "2016",

doi = "10.1136/annrheumdis-2014-205698",

language = "English",

volume = "75",

pages = "356--361",

journal = "Annals of the Rheumatic Diseases",

issn = "1468-2060",

publisher = "BMJ Publishing Group",

number = "2",

}

Kastbom, A, Forslind, K, Ernestam, S, Geborek, P , Karlsson, J , Petersson, I, Saevarsdottir, S, Klareskog, L, van Vollenhoven, RF & Lundberg, K 2016, 'Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.', Annals of the Rheumatic Diseases, vol. 75, no. 2, pp. 356-361. https://doi.org/10.1136/annrheumdis-2014-205698

TY - JOUR

T1 - Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

AU - Kastbom, Alf

AU - Forslind, Kristina

AU - Ernestam, Sofia

AU - Geborek, Pierre

AU - Karlsson, Johan

AU - Petersson, Ingemar

AU - Saevarsdottir, Saedis

AU - Klareskog, Lars

AU - van Vollenhoven, Ronald F

AU - Lundberg, Karin

PY - 2016

Y1 - 2016

N2 - To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic outcome in early rheumatoid arthritis (RA).

AB - To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic outcome in early rheumatoid arthritis (RA).

U2 - 10.1136/annrheumdis-2014-205698

DO - 10.1136/annrheumdis-2014-205698

M3 - Article

C2 - 25550338

SN - 1468-2060

VL - 75

SP - 356

EP - 361

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 2

ER -

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this